Form 8-K - Current report:
SEC Accession No. 0001213900-20-012809
Filing Date
2020-05-18
Accepted
2020-05-18 16:10:48
Documents
9
Period of Report
2020-05-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0121848-8k_citiuspharma.htm 8-K 31316
2 FORM OF WARRANT ea0121848ex4-1_citiuspharma.htm EX-4.1 97170
3 FORM OF PA WARRANT ea0121848ex4-2_citiuspharma.htm EX-4.2 101119
4 LEGAL OPINION ea0121848ex5-1_citiuspharma.htm EX-5.1 7149
5 FORM OF SECURITIES PURCHASE AGREEMENT ea0121848ex10-1_citiuspharma.htm EX-10.1 229001
6 LETTER AGREEMENT BETWEEN CITIUS PHARMACEUTICALS, INC. AND H.C. WAINWRIGHT & CO., ea0121848ex10-2_citiuspharma.htm EX-10.2 58586
7 PRICING PRESS RELEASE ea0121848ex99-1_citiuspharma.htm EX-99.1 10449
8 PRESS RELEASE OF MAY 18, 2020. ea0121848ex99-2_citiuspharma.htm EX-99.2 8994
9 GRAPHIC ex99-1_001.jpg GRAPHIC 7349
  Complete submission text file 0001213900-20-012809.txt   555455
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-38174 | Film No.: 20889629
SIC: 2834 Pharmaceutical Preparations